| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/1521-2254(200011/12)2:6<444::AID-JGM132>3.0.CO;2-1 |
| P698 | PubMed publication ID | 11199265 |
| P2093 | author name string | O'Riordan CR | |
| Wadsworth SC | |||
| Vincent KA | |||
| Lachapelle AL | |||
| P2860 | cites work | Persistent expression of human clotting factor IX from mouse liver after intravenous injection of adeno-associated virus vectors | Q24683259 |
| Characteristics of a human cell line transformed by DNA from human adenovirus type 5 | Q29547863 | ||
| Gene delivery to skeletal muscle results in sustained expression and systemic delivery of a therapeutic protein | Q35943644 | ||
| Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus | Q36242842 | ||
| Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina | Q36439639 | ||
| Stable in vivo expression of the cystic fibrosis transmembrane conductance regulator with an adeno-associated virus vector | Q36663364 | ||
| High-titer adeno-associated viral vectors from a Rep/Cap cell line and hybrid shuttle virus | Q40992577 | ||
| A phase I study of an adeno-associated virus-CFTR gene vector in adult CF patients with mild lung disease | Q41192401 | ||
| Purification of a type 5 recombinant adenovirus encoding human p53 by column chromatography | Q41275967 | ||
| Development and Analysis of Recombinant Adenoviruses for Gene Therapy of Cystic Fibrosis | Q41540042 | ||
| Long-term gene expression and phenotypic correction using adeno-associated virus vectors in the mammalian brain | Q42280576 | ||
| Persistent and therapeutic concentrations of human factor IX in mice after hepatic gene transfer of recombinant AAV vectors | Q43716886 | ||
| Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector | Q43783192 | ||
| Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield | Q45747699 | ||
| Purification of recombinant adeno-associated virus by iodixanol gradient ultracentrifugation allows rapid and reproducible preparation of vector stocks for gene transfer in the nervous system | Q45747815 | ||
| Highly purified recombinant adeno-associated virus vectors are biologically active and free of detectable helper and wild-type viruses | Q45749766 | ||
| Novel tools for production and purification of recombinant adenoassociated virus vectors | Q45752072 | ||
| Recombinant adeno-associated virus for muscle directed gene therapy | Q45764433 | ||
| Differential and persistent expression patterns of CNS gene transfer by an adeno-associated virus (AAV) vector | Q45769447 | ||
| Persistent transgene product in retina, optic nerve and brain after intraocular injection of rAAV. | Q48169737 | ||
| Purification of an adenovirus-coded DNA polymerase that is required for initiation of DNA replication | Q53563525 | ||
| Replication of a human parvovirus nonsense mutant in mammalian cells containing an inducible amber suppressor | Q64379115 | ||
| Recombinant adeno-associated viral vectors mediate long-term transgene expression in muscle | Q73254110 | ||
| The kinetics of rAAV integration in the liver | Q74557678 | ||
| P433 | issue | 6 | |
| P304 | page(s) | 444-454 | |
| P577 | publication date | 2000-11-01 | |
| P1433 | published in | Journal of Gene Medicine | Q15746377 |
| P1476 | title | Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV). | |
| P478 | volume | 2 |
| Q33713203 | A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells |
| Q99633345 | AAV Production Everywhere: A Simple, Fast, and Reliable Protocol for In-house AAV Vector Production Based on Chloroform Extraction |
| Q46455025 | AAV vector-mediated correction of brain pathology in a mouse model of Niemann-Pick A disease |
| Q81058015 | AAV8-mediated hepatic expression of acid sphingomyelinase corrects the metabolic defect in the visceral organs of a mouse model of Niemann-Pick disease |
| Q42143560 | Activation of the unfolded protein response enhances motor recovery after spinal cord injury |
| Q39686372 | Addition of six-His-tagged peptide to the C terminus of adeno-associated virus VP3 does not affect viral tropism or production |
| Q59349590 | Adeno-Associated Virus Production, Purification, and Titering |
| Q35216648 | Adeno-associated viral vectors. |
| Q45365704 | Adeno-associated virus-mediated expression of acid sphingomyelinase decreases atherosclerotic lesion formation in apolipoprotein E(-/-) mice |
| Q36288920 | Chromatographic purification of recombinant adenoviral and adeno-associated viral vectors: methods and implications |
| Q35803520 | Combination brain and systemic injections of AAV provide maximal functional and survival benefits in the Niemann-Pick mouse |
| Q28509073 | Control of dopaminergic neuron survival by the unfolded protein response transcription factor XBP1 |
| Q45457148 | Correction of glycogen storage disease type II by an adeno-associated virus vector containing a muscle-specific promoter |
| Q33792012 | Cytotoxic T lymphocyte responses to transgene product, not adeno-associated viral capsid protein, limit transgene expression in mice |
| Q37944322 | Downstream processing of cell culture-derived virus particles |
| Q36288881 | Downstream processing of viral vectors and vaccines |
| Q30477455 | Effective gene therapy in an authentic model of Tay-Sachs-related diseases |
| Q34202095 | Gene transfer of human acid sphingomyelinase corrects neuropathology and motor deficits in a mouse model of Niemann-Pick type A disease |
| Q41098235 | Identification of an adeno-associated virus binding epitope for AVB sepharose affinity resin |
| Q45887500 | Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice |
| Q39756417 | Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification |
| Q39050550 | Influence of peptide ligand surface density and ethylene oxide spacer arm on the capture of porcine parvovirus |
| Q34982857 | Large-scale recombinant adeno-associated virus production |
| Q35904461 | Recombinant adeno-associated viral (rAAV) vectors as therapeutic tools for Duchenne muscular dystrophy (DMD). |
| Q33555259 | Scalable downstream strategies for purification of recombinant adeno- associated virus vectors in light of the properties |
| Q90178596 | Sequential two-step chromatographic purification of infectious poliovirus using ceramic fluoroapatite and ceramic hydroxyapatite columns |
| Q36729692 | The use of recombinant adeno-associated virus for skeletal gene therapy |
| Q44039833 | Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease |
| Q47551574 | Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes |
Search more.